Market Signal Briefing

Cocoon, the first privacy-focused decentralized AI platform based on The Open Network (TON), is now live. The launch is one of the most significant developments in making AI computational power accessible to humans via a blockchain protocol.

Solana's blockchain ecosystem is experiencing a sudden burst of activity, with the token MON rapidly gaining attention and driving massive trading volumes. According to Solana Daily, MON recorded over $400 million in trading volume within just 48 hours, completing 360,000 trades and drawing more than 21,000 unique traders.

Blackrock, the world's preeminent asset manager, has reported that its spot Bitcoin exchange-traded funds (ETFs) are a top driver of its soaring profits, with current allocations approaching $100 billion. This landmark achievement highlights the growing mainstream acceptance of cryptocurrency investments.

Cover image via www.freepik.com

Disclaimer: The opinions expressed by our writers are their own and do not represent the views of U.Today. The financial and market information provided on U.Today is intended for informational purposes only. U.Today is not liable for any financial losses incurred while trading cryptocurrencies. Conduct your own research by contacting financial experts before making any investment decisions. We believe that all content is accurate as of the date of publication, but certain offers mentioned may no longer be available.

The market's position is getting worse as arch-like patterns appear across the board. Usually it means that the rally is fading and bears are going to take control as the new trading week starts. Unfortunately, at the current rate, a swift and explosive recovery is nearly impossible.

Shiba Inu's recovery endsThe current chart completely destroys any hope that Shiba Inu could salvage a significant recovery phase. The alleged uptrend that briefly surfaced earlier this month was actually a dead-cat bounce inside a clearly defined, protracted downtrend. And now it has run directly into the same wall, the cluster of declining moving averages that has rejected SHIB for nearly a full year.

SHIB/USDT Chart by TradingViewThere is no space for interpretation in the technicals. The 50-day, 100-day and 200-day major moving averages are all pointing downward, and SHIB is trading beneath them. This alignment is a fully confirmed, bearish stack, not neutral. Any asset that falls between those three curves is using no leverage to fight gravity.

HOT Stories

Like every other failed bounce since June, SHIB has now tapped the underside of the 50-day EMA and failed. That is the point at which feeble relief efforts fail.

The same story is confirmed by volume. There is no buy-side activity despite a slight price increase from the November lows. There isn’t any momentum, breakout volume or accumulation at all. Volume increases when a market tries to turn around, but SHIB’s has had the opposite effect.

Indeed, since the uptrend never began, it ends here. With lower highs and lower lows dominating every time frame, SHIB is still stuck in a more general, structural decline. This asset has no technical foundation for a bullish narrative until the price breaks above $0.0000099 and then the 200-day MA around $0.00001186.

Bitcoin is back in dangerBitcoin has risen back into the danger zone, directly confronting the resistance level of $90,954, which has frequently served as a significant turning point for the asset. This is the point on the chart where sentiment breaks down, liquidity tightens and the market begins acting irrationally. It is not just another arbitrary line. This is where Bitcoin will either soar higher or crash back into the mid-$80,000s.

The structure of the daily chart is simple: Bitcoin is rebounding from a severe sell-off in November, but it is currently running into layered resistance from the 20-day EMA, 50-day EMA and a structural ceiling that was established in the early phases of the prior decline. BTC is attacking these bearishly stacked moving averages from below, which is the least favorable position for a breakout attempt.

BTC/USDT Chart by TradingViewMoreover, volume is not helping. There is buying pressure, but it is not motivated by conviction. This kind of expansion is not typical of a clean breakout. This type of cautious action frequently comes before volatility spikes and fakeouts.

You Might Also Like

The RSI is in the neutral-to-slightly-bullish range, indicating recovery momentum but insufficient strength to overwhelm a significant resistance cluster by itself. And that is where things get weird. The market frequently exhibits unpredictable behavior, including stop-hunts, liquidation cascades, false breakouts and sharp intraday swings of 2-5% when Bitcoin gets close to a level that both bulls and bears are fixated on.

The setup is ready for chaotic price action because traders are still trying to buy the dip or short the bounce with inflated open interest. BTC can move toward $94,400 and possibly $102,000 if it breaks above $90,954 cleanly and maintains a daily close. However, the price could swiftly return to the $87,000-$88,000 range if it is rejected, which is totally possible given the current technicals.

XRP takes a hitWith the 50-day EMA falling below the 100-day EMA, XRP has just locked in a mini-death cross, and the timing could not be worse for bulls. Although this crossover lacks the catastrophic weight of a 50/200 EMA death cross, it nevertheless indicates a structural decline in medium-term momentum and, historically, frequently signals the start of unsuccessful recovery attempts.

That dynamic is exactly what the chart illustrates. Although XRP has been steadily rising from its recent lows, the bounce is feeble, shallow, and has already stalled just below the declining 50/100/200 EMA cluster. The price has been unable to break the ceiling formed by these moving averages, which are stacked in an aggressively bearish manner for weeks. Every time XRP rises, sellers intervene right away; this is typical behavior during a downtrend when bulls lack sufficient strength.

You Might Also Like

Volume attests to the weakness. There is no growth, no influx of new purchasers and no indication of accumulation. The RSI is neither oversold nor exhibiting any breakout momentum as it drifts sideways around the mid-40s. Bearish crossovers have teeth in this type of environment because there is nothing to offset them.

Instead of a breakout, the mini-death cross indicates that the market is getting ready for another leg down. The recovery attempt fails if XRP is unable to recover $2.33 (the 50 EMA zone), leaving the asset susceptible to a decline back toward $2.10-$2.00, with even lower levels possible if sentiment deteriorates.

Although a clean daily close above the 100 EMA would neutralize the signal, bulls still have a limited escape route, but nothing in the current price behavior points to that happening anytime soon.

Journalist

Posted: December 1, 2025

Dogecoin still maintained the top-10 position despite dropping below $0.15. The last week of November has been bullish, but DOGE has only managed a gain of about 4% this week.

The market cap for the memecoin traded at $22 billion at press time. Recent activity on the chain could explain the current trend in DOGE.

This decline occurs against the backdrop of Vitalik Buterin’s old remarks about Dogecoin [DOGE], which have been resurfacing. Back then, Vitalik heaped praise on DOGE during the interview.

Will the memecoin bounce from the current dip, or will the price continue declining?

Worrying Dogecoin activity!
According to data from Santiment, the whale transaction count, which involved over $1 million positions, dropped heavily in the past two months. The number declined from 285 to below 38 when writing.

The decrease meant the institutions and influential individuals were easing their involvement with the DOGE market. That way, prices have stayed below 2024 pre-election levels in this two-month retracement.

Source: Ali Charts/X

Since then, the overlaid price action of Dogecoin has dropped from $0.271 to as low as $0.13. Such major drops have marked key market turns in the past, but was that aligning with any other on-chain signal?

How are participants acting?
Data from CryptoQuant showed that whales were active on the Spot market as opposed to the Futures one, meaning they were accumulating. However, this accumulation was slow, as the aforementioned data indicated.

On the other hand, the Futures market was crowded by retail when writing. This helped explain why the market was sluggish, as retailers have limited capital that can push the price of assets.

Source: CryptoQuant

The market sentiment gauge reflected the participants’ activities. Whales and retail once again showed their differences.

The crowd, which was active in the Futures market, was bearish at press time, with a reading of 1.31. This meant they were selling the memecoin, explaining the struggles in price.

Source: Market Prophit

Though very few, the Smart Money buyers were faintly bullish. This presented contrasting data for the next price outlook of Dogecoin.

Will DOGE rally next?
The charts showed that Dogecoin had broken below a key price level. Historical data for Q4 2024 showed that the breakdown of the two-touched support level was followed with a price rally.

Trader Tardigrade, an analyst on X, noted that Dogecoin could see a pump, potentially surpassing the $0.60 threshold.

This was likened to the previous drop after Dogecoin fell below the second support level, as indicated on the chart.

Source: Trader Tardigrade/X

However, this is dependent on the bigger outlook of the crypto market. Markets were struggling, and so was Dogecoin, but the current retracement in chain activity and price action could be coming to an end.

Final Thoughts 

Dogecoin activity dips as the price follows with it; whales and retail stay divided in sentiment.
Dogecoin’s technical outlook could be hinting at a looming rally if history repeats.

The Converge blockchain was scheduled to launch in the second quarter of 2025, but its launch "doesn't appear to be planned for the near future."

2 hours ago

The comments followed S&P's downgrade of USDt's ability to maintain its peg, which cited Tether's Bitcoin and gold reserves as a concern.

Tether CEO Paolo Ardoino and market analysts pushed back against S&P Global’s downgraded rating of USDt’s (USDT) ability to maintain its US dollar peg, saying that the ratings agency did not account for all of Tether’s assets and revenues.

The Tether Group’s total assets at the end of Q3 2025 totaled about $215 billion, while its total stablecoin liabilities were about $184.5 billion, according to Ardoino, who referenced Tether’s Q3 attestation report. He added:

“Tether had, at the end of Q3 2025, about $7 billion in excess equity, on top of the about $184.5 billion in stablecoin reserves, plus about another $23 billion in retained earnings as part of our Tether Group equity. S&P made the same mistake of not considering the additional Group Equity, nor the roughly $500 million in monthly base profits generated by US Treasury yields alone,” Ardoino continued.

Source: Paolo ArdoinoS&P Global downgraded USDt’s dollar-peg rating to “weak”  on Wednesday, the lowest score on its scale, prompting fear, uncertainty, and doubt from some analysts about the company, which has become a critical piece of crypto market infrastructure.

Analysts debate Tether’s balance sheet fundamentalsArthur Hayes, a market analyst and founder of the BitMEX crypto exchange, speculated that Tether is buying large quantities of gold and BTC to compensate for income shortfalls produced by falling US Treasury yields.

As the Federal Reserve slashes interest rates, the gold and BTC should go up in value, Hayes said, but he also warned that a steep correction in these assets could spell trouble for Tether.

“A roughly 30% decline in the gold and BTC position would wipe out their equity, and then USDt would be, in theory, insolvent,” he said.

Source: Arthur HayesJoseph Ayoub, the former lead digital asset analyst at financial services giant Citi, said he spent “hundreds” of hours researching Tether as an analyst for the company, and rebuffed Hayes’ analysis.

Tether has excess assets beyond what it reports, has an extremely lucrative business that generates billions of dollars in interest income with only 150 employees, and is better collateralized than traditional banks, Ayoub said. 

Magazine: GENIUS Act reopens the door for a Meta stablecoin, but will it work?

In November 2025, the cryptocurrency market continues to experience significant volatility, with Dogecoin (DOGE) at the center of attention due to the shifting dynamics between retail traders and larger investors, often referred to as ‘whales.' Recent data shows a notable decrease in large-scale transactions, with DOGE whales stepping back, allowing retail investors to dominate.

The real-world asset market has been recovering after a slow November, with fresh interest emerging from stablecoin experiments and strong technical setups. Activity remains uneven across the sector, but a few charts are setting up more cleanly than the others.

Among the key RWA tokens to watch, three stand out as December approaches. Each shows a different mix of strength, recovery potential, and risk.

Stellar (XLM)Among key RWA tokens to watch in December, Stellar (XLM) stands out as a payments-first chain that big financial players actually use.

Sponsored

Sponsored

November was still rough, with XLM down about 18.9%, but the last seven days brought a 4.9% bounce as US Bank’s stablecoin tests and growing AUDD activity pushed fresh attention toward the network.

On the chart, Stellar is quietly building a reversal setup. Between November 4 and November 21, the price reached a lower low; however, the Relative Strength Index (RSI) formed a higher low.

RSI measures momentum on a 0–100 scale, so this “price down, RSI up” pattern, standard bullish divergence, often hints that selling pressure is fading under the surface.

The rebound began immediately after that signal, yet XLM remains trapped in a tight range between $0.253 and $0.264. A clean daily close above $0.264 is the first sign that bulls are back in control.

If that happens, the next upside areas to watch are $0.275 and then $0.324 if the broader market improves.

Stellar Price Analysis: TradingViewWant more token insights like this? Sign up for Editor Harsh Notariya’s Daily Crypto Newsletter here.

If the XLM price falls below $0.239 instead, the bullish setup weakens, and the move could stretch toward $0.217, delaying any RWA-driven recovery story.

Sponsored

Sponsored

Quant (QNT)Quant is the clear outlier among RWA tokens to watch right now. While most real-world-asset plays struggled through November, QNT moved in the opposite direction. It is up about 32% this month and roughly 37% in the past seven days. In the last 24 hours alone, the token added another 12%, making it one of the strongest charts in this segment.

Quant sits at the center of the “interoperability for finance” narrative. Its Overledger tech connects private and public blockchains, which is why it often reacts earlier than other RWA coins when institutional demand strengthens.

On the chart, momentum is still building. QNT is close to forming a bullish EMA (Exponential Moving Average) crossover on the daily chart, where the 20-day EMA is about to move above the 50-day EMA.

This setup often signals that buyers are gaining control. If the crossover completes, Quant (QNT) could have room for another strong push.

The EMA, or Exponential Moving Average, is a trend line that gives more weight to recent prices, allowing traders to see short-term momentum more clearly.

The first level to clear is $119. This level lines up with the 1.618 Fibonacci extension. If buyers stay active, even $142 comes into view as the next major resistance.

Sponsored

Sponsored

ONDO Price Analysis: TradingViewOn the downside, $100 is the first support to watch. Losing that level can force QNT back toward $91 and $87. The broader bullish structure breaks only if the token falls below $82. This is the point at which the current uptrend stops making sense.

For now, Quant remains the most resilient name in this RWA group and carries the strongest momentum heading into December.

Ondo (ONDO)Ondo sits in an interesting spot among the key RWA tokens’ list. It is up 9.3% over the past seven days but remains one of the weakest performers on a 30-day view, down 25%.

Interest around the token increased this week after a post highlighted that Ondo Finance may extend tokenized US stocks and ETFs across Europe.

If this direction holds, it could add weight to Ondo’s role in the broader RWA space. And that could even impact the price action.

Sponsored

Sponsored

🚨 BREAKING: TOKENIZED STOCKS GO GLOBAL

Ondo Finance will begin offering tokenized U.S. stocks and ETFs across Europe. 🇺🇸🇪🇺

This is not a pilot.
This is U.S. markets going fully on-chain for international investors.

RWAs are taking over. pic.twitter.com/ioYjRQ5h7J

— Merlijn The Trader (@MerlijnTrader) November 28, 2025
That uncertainty shows up on the chart. Ondo has posted a steady rebound since November 21, but the more significant development is evident in its OBV line.

OBV, or on-balance volume, measures whether buying volume is stronger than selling volume over time. Ondo’s OBV has broken above the descending trendline in place since early November.

This breakout occurred while the price has been stuck between $0.50 and $0.54 since November 27, which suggests that accumulation may be forming beneath the surface.

For upside movement, the first step is a clean close above $0.54. That level sits about 6% above the current price. Clearing it can pave the way for a move toward $0.60, and a stronger market could push the ONDO price toward $0.70.

ONDO Price Analysis: TradingViewIf OBV fails to hold above the breakout line and slips back under it, the move becomes a fake-out. In that case, losing $0.50 becomes more likely, and the next key support is near $0.44.

Among the RWA tokens, ONDO has the most balanced setup. It has the structure to move higher if accumulation continues, but the same range can break on the downside if OBV weakens again.

On November 30, 2025, the cryptocurrency PIPPIN witnessed an incredible increase of 345% from its weekly lows, attracting substantial attention from investors and analysts alike. This dramatic rise in value has seen PIPPIN's price climb to new heights, sparking discussions about its potential as a lucrative investment opportunity.

Ripple's regulated stablecoin RLUSD has crossed a major milestone, reaching more than $1 billion in supply on Ethereum amid rising global demand for compliant digital assets. The rapid growth highlights how the stablecoin market continues expanding even as broader crypto prices face volatility.

What mNAV Really Tells You About Bitcoin Treasury Companies — and Where It Falls ShortNYDIG’s research head questions how mNAV is used to assess bitcoin treasuries, arguing it masks key risks tied to capital structure and equity dilution. Nov 30, 2025, 9:45 p.m.

mNAV has become the go-to valuation shorthand for bitcoin treasury stocks — but a growing number of analysts are warning it oversimplifies the story.

The rise of mNAV in bitcoin financeOver the past few years, a class of publicly traded companies has emerged whose primary value proposition is holding bitcoin on their balance sheets. These “bitcoin treasuries” — including firms like Strategy (MSTR), formerly known as MicroStrategy — have sparked debate among investors, especially when their stocks trade at levels disconnected from the value of the BTC they hold.

STORY CONTINUES BELOW

The most common valuation yardstick is the multiple of net asset value (mNAV). It compares a company's enterprise value (EV) to the market value of its bitcoin holdings, giving investors a way to assess how much of a premium or discount the market assigns to its treasury.

mNAV ≈ enterprise value ÷ bitcoin holdings value

The metric is now widely followed. Strategy publishes its own mNAV on its investor site, while third-party dashboards such as BitcoinTreasuries.net track various mNAV figures across multiple firms.

How mNAV worksA basic mNAV calculation involves:

Estimating the market value of the company’s BTC stack using current prices.Calculating enterprise value: market cap + debt – cash equivalents.Dividing EV by BTC holdings to get the multiple.This EV-based approach represents just one way to compute mNAV. Depending on how analysts treat debt, cash, and potential share dilution, the ratio can shift significantly — which is why the industry now tracks multiple variants.

A reading above 1.0 implies a premium, while a reading below 1.0 suggests a discount — potentially a red flag or an opportunity, depending on the investor's outlook.

While Strategy reports an enterprise‑value-based mNAV on its investor site, third‑party data providers publish multiple versions of the metric — each reflecting different assumptions about capital structure and share count.

How to read mNAV: premium, parity, discountOnce calculated, mNAV gives a sense of how markets are valuing a firm's bitcoin exposure:

mNAV > 1:
The stock trades at a premium to the value of its bitcoin. Investors may be assigning extra value for capital market access, future BTC accumulation potential, or an operating business.mNAV ≈ 1:
The firm trades at a price close to the value of its BTC holdings. This suggests it's being valued like a direct bitcoin proxy, with little added or subtracted for other factors.mNAV < 1:
The stock trades at a discount to its BTC holdings — a sign investors aren’t willing to pay even full price for the coins on the balance sheet. This can raise concerns about execution or capital structure, but some value investors see it as a buying opportunity.Because mNAV is a dimensionless ratio, it allows comparisons across firms regardless of treasury size or share count. It also reflects broader market sentiment about whether investors trust the firm's overall strategy.

Understanding the variants: basic, diluted, and EV mNAVSome dashboards, e.g., BitcoinTreasuries.net, now show multiple mNAV variants:

mNAV Basic
A simple ratio using the current market cap and BTC holdings, with no adjustments for future share dilution.mNAV Diluted
Adjusts for convertible notes and other instruments by increasing the share count. This gives a more conservative view of what shareholders “really” own.mNAV EV
Uses enterprise value instead of market cap to incorporate debt and other liabilities. This version is especially useful when a firm, such as Strategy, has issued long-dated convertibles and holds substantial liabilities.As of Nov. 30, Strategy’s reported values were:

mNAV Basic: 0.856mNAV Diluted: 0.954mNAV EV: 1.105That means equity investors may be paying slightly less than $1 per dollar of BTC on a diluted basis, while the broader market — including debt holders — still values the firm above its BTC holdings.

Why it mattersmNAV has real implications for capital markets activity. A firm trading above 1.0 can raise equity or debt at favorable terms and buy more bitcoin, effectively increasing its exposure. When mNAV drops, that playbook becomes harder or more dilutive.

Because of that feedback loop, mNAV influences how companies approach financing — and how investors assess the viability of bitcoin-first business models.

The NYDIG critiqueIn a June 2025 blog post, Greg Cipolaro, the global head of research at NYDIG, offered a sharp critique of mNAV as it’s commonly used. He argued the metric is “woefully deficient” for failing to reflect key balance sheet risks — especially assumptions about convertible notes.

Many analysts, Cipolaro noted, treat these convertibles as if they’re guaranteed to convert into equity. But if market triggers aren’t met, the notes might have to be repaid in cash, creating a refinancing risk that mNAV fails to capture.

Cipolaro also flagged that mNAV often ignores the value of the operating company (opco), which could be a source of hidden risk or upside. Instead of scrapping the metric, he suggested refining it to incorporate more robust modeling of capital structure and opco valuation.

The road aheadmNAV remains the most cited metric for comparing bitcoin treasury stocks, but critiques like Cipolaro’s suggest it may need an upgrade. Investors are increasingly calling for more transparency and standardization — especially as more firms adopt bitcoin-forward treasury strategies.

With bitcoin treasuries growing in number and complexity, the question is no longer just “what’s the multiple?” but “what’s actually in it?”

AI Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.

More For You

Protocol Research: GoPlus Security

Nov 14, 2025

What to know:

As of October 2025, GoPlus has generated $4.7M in total revenue across its product lines. The GoPlus App is the primary revenue driver, contributing $2.5M (approx. 53%), followed by the SafeToken Protocol at $1.7M.GoPlus Intelligence's Token Security API averaged 717 million monthly calls year-to-date in 2025 , with a peak of nearly 1 billion calls in February 2025. Total blockchain-level requests, including transaction simulations, averaged an additional 350 million per month.Since its January 2025 launch , the $GPS token has registered over $5B in total spot volume and $10B in derivatives volume in 2025. Monthly spot volume peaked in March 2025 at over $1.1B , while derivatives volume peaked the same month at over $4B.View Full Report

More For You

Priced at Zero: How Brazil’s Méliuz Turned to Bitcoin to Escape a Treasury Trap

4 hours ago

The company adopted a bitcoin treasury plan by deploying a strategy inspired by Metaplanet, with 66% shareholder approval, to mitigate negative returns from government bonds.

What to know:

Méliuz, a Brazilian fintech firm, pivoted to bitcoin after discovering that its market value was zero, despite being profitable and debt-free.The company adopted a bitcoin treasury strategy, with 66% shareholder approval, to escape negative returns from government bonds.Méliuz employs a strategy inspired by Metaplanet, using derivatives to generate yield, while maintaining 80% of its bitcoin in cold storage.Read full story

The stablecoin market has witnessed a notable rebound, growing by over $3 billion in the past week, following a dip from its October peak of $309 billion to $302 billion by November 22. This resurgence is largely driven by a renewed interest in USD Coin (USDC), highlighting its role in the broader cryptocurrency ecosystem and signaling a possible trend reversal.

The complex attack took place in a single transaction, and appears to have involved liquid staking tokens from across the Ethereum ecosystem.

Ethereum is showing renewed signs of strength after a period of heavy market pressure. The cryptocurrency has held the $2,990 support level, opening the possibility for a push toward the $3,400 target in the near term.

The metric known as multiple of net asset value, or mNAV, has quickly become a popular way to value publicly traded “bitcoin treasury” companies — firms whose primary strategy is holding bitcoin on their balance sheets. As companies like Strategy (MSTR) continue accumulating BTC, investors rely on mNAV to understand whether these stocks trade at a premium, at parity, or at a discount relative to the underlying bitcoin they hold. But as its use grows, so does criticism that the metric oversimplifies complex capital structures and risks.

mNAV is typically calculated by dividing a company’s enterprise value by the market value of its bitcoin holdings. Because it’s a simple ratio, it lets investors compare bitcoin-heavy firms of different sizes. A reading above 1.0 means the stock trades at a premium to the BTC on its balance sheet, often signaling investor confidence in a firm’s strategy or its ability to raise capital and buy more bitcoin. A value near 1.0 suggests the market sees the stock as a direct proxy for BTC, while readings below 1.0 indicate a discount that some view as an opportunity and others as a warning.

Different versions of mNAV exist because the metric can shift based on assumptions about debt, cash, and share dilution. Basic mNAV uses market cap alone. Diluted mNAV accounts for convertible debt that could increase share count. EV-based mNAV incorporates liabilities and is often viewed as more realistic. As of Nov. 30, Strategy reported an mNAV Basic of 0.856, a diluted mNAV of 0.954, and an EV-based mNAV of 1.105 — showing how varied outcomes can be depending on the approach.

While widely used, mNAV has notable critics. NYDIG’s Greg Cipolaro argues the metric is “woefully deficient” because it often treats convertibles as guaranteed equity conversion and ignores the possibility of repayment in cash, which creates refinancing risk. He also notes that mNAV typically overlooks the value or risk within the operating business itself. Rather than abandoning the metric, he calls for refining it to better reflect real-world balance sheet dynamics.

With more companies adopting bitcoin-forward treasury strategies, mNAV will likely remain an important benchmarking tool. But as capital structures grow more complex, investors are increasingly focused not just on the multiple — but on what that multiple might be missing.

<Copyright ⓒ TokenPost, unauthorized reproduction and redistribution prohibited>

One hedge fund just made a bold bet on a beaten-down chemicals giant—here’s what long-term investors should know.

New York City-based Cooper Creek Partners Management disclosed a new position in The Chemours Company (CC +2.57%) during the third quarter, adding nearly 4 million shares valued at $63.1 million, according to a November 14 SEC filing.

What HappenedAccording to a filing with the U.S. Securities and Exchange Commission dated November 14, Cooper Creek Partners Management initiated a new position in The Chemours Company (CC +2.57%), acquiring nearly 4 million shares during the third quarter. The stake was valued at $63.1 million as of September 30. To compare, the fund reported total U.S. equity holdings of $3.3 billion across 88 positions for the quarter.

What Else to KnowThe purchase established a new position representing 1.9% of the fund’s 13F reportable assets under management.

Top holdings after the filing: 

NYSE:OI: $130.5 million (4.9% of AUM)NASDAQ:NWL: $130.2 million (4.9% of AUM)NYSE:CXW: $129.7 million (4.9% of AUM)NYSE:BBWI: $129 million (4.8% of AUM)NYSE:AAP: $107 million (4% of AUM)As of Friday's market close, Chemours shares were priced at $12.79, down 41% over the past year and well underperforming the S&P 500, which is up 14% in the same period.

Company OverviewMetricValueRevenue (TTM)$5.8 billionNet income (TTM)($320 million)Dividend yield2.7%Price (as of market close Friday)$12.79Company SnapshotThe Chemours Company produces titanium dioxide pigments, refrigerants, advanced performance materials, and industrial chemicals, with key brands including Ti-Pure and BaiMax. The company leverages its advanced technologies and established brands to supply critical materials for high-value applications in multiple end markets, and it serves a diverse customer base across industries such as coatings, packaging, electronics, automotive, energy, and water treatment, primarily targeting industrial and commercial clients worldwide.

Foolish TakeA big new position in an out-of-favor chemicals name seems like a signal that a fund sees value that the broader market is missing. Chemours fits that profile. The stock is down more than 40% this year and remains nearly 80% below its 2017 peak, but its latest earnings show a company stabilizing after operational disruptions and still generating meaningful cash flow despite soft industrial demand.

Cooper Creek Partners built a significant new stake in The Chemours Company during the third quarter that represents 1.9% of the fund’s 13F assets, a notable allocation for a portfolio of 88 holdings.

Chemours posted $1.5 billion in third-quarter revenue—roughly flat year over year—and $60 million in net income, reversing a $32 million loss from the prior-year quarter. Strength in Opteon refrigerants offset weakness in titanium dioxide and advanced materials, and management reaffirmed that strategic execution remains on track. As CEO Denise Dignam noted, “Our consolidated results exceeded our expectations for the quarter,” highlighting progress on operational stability.

For investors, the combination of depressed valuation, improving operations, and a new institutional buyer makes Chemours a potential turnaround idea—though its leverage and end-market cyclicality still require patience.

Glossary13F reportable assets: The total value of U.S. equity holdings that an institutional investment manager must disclose in quarterly SEC Form 13F filings.
Assets under management (AUM): The total market value of investments managed on behalf of clients by a fund or firm.
Position: The amount of a particular security or asset held by an investor or fund.
Dividend yield: Annual dividends per share divided by the share price, expressed as a percentage.
Forward P/E ratio: The current share price divided by projected earnings per share over the next 12 months.
Enterprise value to EBITDA: A valuation metric comparing a company's total value to its earnings before interest, taxes, depreciation, and amortization.
Stake: The ownership interest or shareholding a person or entity has in a company.
Trailing twelve months (TTM): The 12-month period ending with the most recent quarterly report.
Initiated a new position: When an investor or fund buys a security for the first time, creating a new holding.
Exposure: The degree to which an investor or fund is invested in a particular asset, sector, or market.

One drug developer could be on the cusp of AI-powered glory.

Shares of the pharmaceutical giant Pfizer (PFE +0.12%) have suffered over the last three years, falling some 50% since December 2022. Shares have been weighed down by the collapse in revenue from its COVID-19 vaccine, Comirnaty, and its COVID-19 pill, Paxlovid, which together brought in over 54% of Pfizer's $100.3 billion in revenue in 2022. In the third quarter of 2025, Paxlovid revenue fell by 55% year over year, while revenue from Comirnaty fell 20%.

Today's Change

(

0.12

%) $

0.03

Current Price

$

25.74

You can see the importance of a few blockbuster treatments for Pfizer by comparing last quarter's revenue to that of Q3 2022. Three years ago, Pfizer reported Q3 revenue of $22.6 billion, compared to $16.7 billion last quarter. Clearly, the enormous tailwind that its COVID-19 vaccine and treatment presented for Pfizer is winding down.

A looming patent cliff has also weighed on its share price. In 2026, its pneumococcal vaccine Prevnar 13 patent will expire, with patents for its anticoagulant Eliquis, its breast cancer treatment Ibrance, and its prostate cancer therapy Xtandis expiring in 2027. Eliquis alone brought in $7.4 billion in revenue in 2024, and all told, the looming patent cliff is expected to affect $236 billion in revenue for pharmaceutical companies worldwide by 2030.

With its steep sell-off since 2022, Wall Street clearly expects Pfizer to endure its share of pain from the global $236 billion hit to big pharma. But there are two major reasons to think Pfizer can not just survive but even thrive during and after the looming patent cliff.

Pfizer's foray into the $133 billion weight loss drug market
Big pharma is well aware that it must build a new pipeline of promising treatments to weather the patent cliff. One of the most straightforward ways to do this is by acquiring companies that have seen promising clinical trial results for potential blockbuster drugs.

This imperative explains Pfizer's acquisition of the biotech start-up Metsera for roughly $10 billion. On Nov. 7, Pfizer scored a major victory over rival Novo Nordisk, when Metsera accepted its bid for a takeover. The deal gives Pfizer a potential entry into the lucrative weight loss drug market, which is expected to be valued at $133 billion by 2030.

Image source: Getty Images.

Metsera has several potential big winners in its pipeline, but the most promising might be its experimental obesity drugs MET-097i (a GLP-1 injectable) and MET-233i, which are projected to reach $5 billion in total annual peak sales.

Here's why the acquisition could be a game-changer for Pfizer: The MET-097i treatment has shown far fewer unpleasant side effects than Wegovy or Ozempic in trials, with weight loss of up to 14.1% over 28 weeks and with no plateau observed. Wegovy and Ozempic cause nausea in between 20% and 44% of users, while MET-097i triggered nausea in just 13%. Throw in that MET-097i is a monthly injection, rather than weekly for Ozempic and Wegovy, and you can see its potential to be hugely preferable as a weight loss treatment.

That's significant because those two drugs brought in $26 billion for Novo Nordisk in 2024. Taking even partial market share could bring in $10 billion a year for Pfizer, eventually paying for its acquisition of Metsera many times over.

Of course, these treatments have to be approved first. But Metsera's other candidates, including an oral weight loss treatment that would allow patients to bypass injections altogether, each provide Pfizer with a potential path to glory.

And that's all before we get to...

Pfizer's head start in AI drug discovery
As far back as 2020, Pfizer was able to create a vaccine for COVID-19 in just 269 days, a feat that ordinarily would have taken eight to 10 years. It was able to do so largely thanks to prolific investments in digital infrastructure that now allow it to process over 50 billion clinical data points annually.

The company's Pfizer-Amazon Collaboration Team (PACT) initiative helps it optimize development of new treatments through cloud-based solutions, with 14 different artificial intelligence (AI) and machine learning projects already combining to save Pfizer's scientists 16,000 hours of search time annually while reducing infrastructure costs by 55%. This state-of-the-art digital infrastructure can also help with regulatory approval, which is half the battle of bringing a drug to market, as Pfizer uses AI in clinical development to create documents, tables, and reports for regulatory filings.

Because it's not unusual for the regulatory review to require tens of thousands of documents, Pfizer's investments in AI and machine learning can dramatically shorten the reviewal process.

This greater efficiency may be a key driver behind Pfizer's recent productivity gains. In Q3 2025, the company reported that it is on track to deliver approximately $7.7 billion in anticipated overall savings while reinvesting another $500 million into research and development.

And while AI is already moving the needle for Pfizer in a big way, investors should note that we're still in the very early days of the era of AI-powered drug discovery. It's been barely a year since Pfizer partnered with the semiconductor giant Nvidia to build its "Ignition AI Accelerator" to leverage AI across every stage of the drug development process.

Of course, Pfizer's competitors are also sparing no expense to ramp up their AI drug discovery platforms. But Pfizer has been leveraging AI technology to accelerate drug development since 2014, and it's no accident that it was the first company to develop and get approval for a COVID-19 vaccine in its partnership with BioNTech.

And even if another company leapfrogs Pfizer in this field, investors shouldn't think of this as a zero-sum game. It's entirely possible for each of the pharma giants to thrive as new AI technologies uncover blockbuster drug candidates at a rate that's hard to conceive of today. The research firm McKinsey & Co forecasts that AI could deliver $110 billion annually for the pharmaceutical industry, so capturing even a portion of that could move the needle for Pfizer shares.

In the meantime, Pfizer offers a dividend yield of 6.9%, which is over 5 times the yield of the average S&P 500 company. And if Pfizer can realize even a fraction of its anticipated total net cost savings by 2027, this payout will likely be safe. In a time when the AI tech titans offer paltry yields or none at all, Pfizer is a buy for income-oriented investors seeking to play the AI revolution.

Tech stocks have been resilient this year despite bouts of volatility, and 2026 could turn out to be another good year for the sector.

The Nasdaq Composite index has registered a gain of about 20% in 2025 so far, and that's quite impressive considering that the index endured a difficult start to the year and pulled back substantially in the first three months.

There is a good chance that the Nasdaq will carry its momentum into 2026. In an interview with CNBC, Ryan Detrick, chief market strategist of investment management firm Carson Group, pointed out that once bull markets hit three years, they tend to stretch to an average of eight years, based on historical trends going back to 1950.

The current bull market turned three years old last month, and the strong quarterly reports from major technology companies suggest that the Nasdaq's rally is indeed sustainable.

Let's say you have $250 to spare right now that you're ready to invest for the long term. You could consider buying one share each of Nvidia (NVDA 1.83%) and Applied Digital (APLD +8.66%) to capitalize on the potential for the tech sector to continue to surge, as these two tech stocks are likely to pop next year.

Image source: Nvidia.

1. Nvidia
The growth of artificial intelligence (AI) chip leader Nvidia isn't showing any signs of slowing down. Shares of the company are up 34% so far in 2025, trading at around $180 as of this writing, and they seem likely to head higher next year. That's because the demand for Nvidia's data center graphics processing units (GPUs) continues to exceed supply.

Today's Change

(

-1.83

%) $

-3.30

Current Price

$

176.96

As CEO Jensen Huang pointed out in the earnings release for its fiscal 2026 third quarter (which ended Oct. 26), "Blackwell sales are off the charts, and cloud GPUs are sold out." He added that the need for its hardware continues to increase thanks to the proliferation of artificial intelligence (AI) systems. The hyperscalers that deploy Nvidia's AI chips in data centers to run AI workloads have already indicated that they are likely to increase their spending on them next year.

Nvidia can already count on some benefits from those higher data center capital expenditures. The company is yet to fulfill booked orders worth $307 billion in the five quarters through the end of 2026; that's significantly higher than the $187 billion in revenue that it has generated in the past four quarters. So it's easy to see why analysts have ramped up their growth expectations for Nvidia for its next fiscal year (which will begin toward the end of January 2026).

NVDA Revenue Estimates for Current Fiscal Year data by YCharts.

Given that Nvidia continues to get more orders for its AI chips, as management indicated on the latest earnings call, it may end up delivering even bigger revenue growth than currently expected. Moreover, it's building up inventory at a solid pace to satisfy its huge backlog. Its inventory was up by 32% last quarter, while supply commitments increased by 63%.

So, it is easy to see why analysts are forecasting a 58% jump in Nvidia's earnings in its fiscal 2027 to $7.43 per share. Nvidia is trading at just 23 times forward earnings right now, lower than the Nasdaq 100 index's price-to-earnings (P/E) ratio of 32. The market could reward Nvidia with a higher multiple in the coming year thanks to the incredible growth that it is expected to deliver, and that's likely to result in more stock price gains.

2. Applied Digital
Applied Digital stock has shot up by an impressive 211% in 2025 to around $24. But it's also down by about 33% from the high it hit in October. Buying the data center specialist's stock following its pullback could turn out to be a profitable move.

Today's Change

(

8.66

%) $

2.16

Current Price

$

27.10

Applied Digital is in the business of designing, building, and operating data centers meant for AI and high-performance computing, and it's currently building two such complexes in North Dakota. The good part is that it has already leased out its data centers for 15 years to CoreWeave and another hyperscale provider. Applied Digital expects to have 700 megawatts (MW) of capacity online by 2027 as compared to its current capacity of 286 MW.

The existing five-year leases that it already has in its kitty represent potential revenue of $16 billion. Even better, Applied Digital has secured $5 billion worth of funding that will help it develop more than 2 gigawatts (GW) -- or 2,000 MW -- of data center capacity in the long run. The company's actual development pipeline, meanwhile, stands at over 4 GW.

Hence, it is easy to see why Applied Digital's growth is expected to take off.

APLD Revenue Estimates for Current Fiscal Year data by YCharts.

Moreover, the growing demand for AI data centers should pave the way for impressive growth at Applied Digital beyond the next couple of years. Of course, the stock is expensive right now at 28 times sales, but the ramp in its revenues should help it justify its valuation. In fact, even if Applied Digital trades at 8.4 times sales after a couple of years (in line with the U.S. technology sector's average sales multiple) and achieves $970 million in revenue that analysts are expecting, its market cap could jump to $8.4 billion.

That would be 27% above current levels, but don't be surprised to see it delivering bigger gains considering its rapid growth and the long-term opportunity in AI data centers, which could lead the market to reward it with a premium valuation. 

Daryl Fairweather of Redfin (@redfin) is seeing more properties coming off the market because homeowners are asking for more than buyers are willing to pay. Low mortgage rates also make sale alternatives like renting to others appealing.

Senior White House officials recently discussed antitrust concerns surrounding Netflix’s interest in acquiring the Warner Bros. studio and the HBO Max streaming service – raising doubts whether such a deal would give Netflix too much power over Hollywood, The Post has learned.

The high-level meeting that took place about 10 days ago hasn’t been previously reported. Several White House officials also suggested during the sitdown that a broader investigation is necessary focusing on Netflix’s market power, a government official who attended the confab said.  

“Basically everyone agreed that Netflix presents unique antitrust concerns and if it won the bidding war it would be one long slog and touch off an investigation along the lines of those of Google and Amazon,” the government official said. 

Netflix’s interest in acquiring Warner Bros. Discovery has raised antitrust concerns at the White House, sources told The Post. Getty Images
“Netflix already has market dominance but if you add a major streaming service that would stifle competition at some point,” the official added.

White House and Netflix press reps had no immediate comment.

The meeting comes as the Warner Bros. Discovery board has scheduled a Monday afternoon deadline to receive a second round of offers for the company. WBD controls the No. 1-ranked Warner Bros. studio and the No 3 streaming service, HBO Max, as well as a slew of cable channels including HBO and CNN.

Paramount Skydance, controlled by Hollywood producer David Ellison and his father, billionaire Oracle co-founder Larry Ellison, is expected to raise its initial bid, which in mid-October came in at $23.50 a share for the entire company.

Cable giant Comcast, run by Brian Roberts, is also expected to sweeten a more recent offer, although it has been given low odds of making it through the Trump regulatory gauntlet because of the president’s disdain for Comcast’s relentlessly anti-MAGA cable channel MSNBC, recently renamed MS NOW. 

Warner Bros. Discovery’s board has scheduled a Monday afternoon deadline to receive a second round of offers for the company. SOPA Images/LightRocket via Getty Images
Meanwhile, Netflix is also expected to make a sweetened bid for WBD’s studio and streaming service – and faces a different but equally difficult set of hurdles getting regulatory approval, Trump officials said during the meeting.

The 28-year-old company created by Reed Hastings and led by its voluble CEO Ted Sarandos is currently the world’s largest streaming service with 300 million subscribers. White House officials at the meeting suggested its size could hamper competition in streaming where Americans increasingly consume their entertainment as cord cutting continues to shrink the cable TV business. They also raised the likelihood of European regulatory push back, the government official said.

Sarandos as well as a slew of company legal officials and lobbyists have been pressing the flesh in DC. As previously reported by The Post, they’ve been pleading a case that an acquisition of the No. 3 streamer and a major studio wouldn’t violate antitrust laws because of a legal theory known as “category ambiguity.”

Netflix chief Ted Sarandos and company legal officials and lobbyists have been pleading the case in Washington, DC that a deal for No. 3 streamer HBO Max and a major studio wouldn’t violate antitrust laws. Alan West/Hogan Media/Shutterstock
According to the theory, antitrust law doesn’t necessarily apply to streaming services because of the prevalence of content that’s available on YouTube, TikTok and other social media. The idea is that streaming video is now so ubiquitous that it can’t be cornered and price gauged in the traditional sense.

But the pitch, while winning converts with members of the WBD board and some quarters of the DC regulatory framework, is now being met with significant skepticism from senior White House officials who advise Trump on media policy, according to a government official who attended the meeting last week. 

Trump officials also voiced concern that Netflix is already wielding enormous power in the Hollywood ecosystem, not just with consumers but also when dealing with program creators and talent. A recurring theme of Trump’s regulatory agenda during his first term and today has been anti-competitive business models of media and tech concentration, the source noted. 

Paramount Skydance, controlled by Hollywood producer David Ellison, above, and his father, billionaire Oracle co-founder Larry Ellison, is expected to raise its initial bid of $23.50 a share for all of Warner Bros. Discovery. Evan Agostini/Invision/AP
If Netflix’s bid won out, the scale and scope of the deal to buy HBO Max and the studio should lead to a lengthy, possibly yearslong probe by the DOJ’s antitrust division run by Trump appointee Gale Slater. The probe could expand beyond the merits of its WBD deal to its entire operations, “something that the company has avoided until now,” the government official who attended said.  

The meeting follows a letter by GOP California congressman Darrell Issa to Slater and her boss US AG Pam Bondi warning that “Netflix currently wields unequaled market power. Adding both HBO Max’s subscribers and Warner Bros.’ premier content rights would further enhance this position.”

But Sarandos may feel he has no choice but to make a run at WBD, and eventually fight off Trump’s regulatory cops in federal court if they nix his bid.

“If Paramount owns all its content plus Warner and HBO they will have control of a massive and quality library, and put Netflix behind the eight-ball in terms of negotiating for WBD content on its streaming service,” a media industry insider told The Post.

Shareholders should contact the firm immediately as there may be limited time to enforce your rights. 

, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Semtech Corporation (NASDAQ: SMTC) breached their fiduciary duties to shareholders.

If you currently own Semtech stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about your legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. Our firm would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Why Your Participation Matters:

Shareholder involvement can help improve a company's policies, practices, and oversight mechanisms to create a more transparent, accountable, and effectively managed organization, which can enhance shareholder value.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
One World Trade Center
85th Floor
New York, NY 10007
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

SOURCE Halper Sadeh LLP

Shareholders should contact the firm immediately as there may be limited time to enforce your rights. 

, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of SolarEdge Technologies, Inc. (NASDAQ: SEDG) breached their fiduciary duties to shareholders.

If you currently own SolarEdge stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about your legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. Our firm would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Why Your Participation Matters:

Shareholder involvement can help improve a company's policies, practices, and oversight mechanisms to create a more transparent, accountable, and effectively managed organization, which can enhance shareholder value.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
One World Trade Center
85th Floor
New York, NY 10007
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

SOURCE Halper Sadeh LLP

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Live Nation Entertainment, Inc. (NYSE: LYV) breached their fiduciary duties to shareholders.

If you currently own Live Nation stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about your legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or  [email protected]. Our firm would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Why Your Participation Matters:

Shareholder involvement can help improve a company's policies, practices, and oversight mechanisms to create a more transparent, accountable, and effectively managed organization, which can enhance shareholder value.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
One World Trade Center
85th Floor
New York, NY 10007
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

SOURCE Halper Sadeh LLP

Shareholders should contact the firm immediately as there may be limited time to enforce your rights.

, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Mercury Systems, Inc. (NASDAQ: MRCY) breached their fiduciary duties to shareholders.

If you currently own Mercury stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about your legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected]. Our firm would handle the action on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

Why Your Participation Matters:

Shareholder involvement can help improve a company's policies, practices, and oversight mechanisms to create a more transparent, accountable, and effectively managed organization, which can enhance shareholder value.

Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:
Halper Sadeh LLC
One World Trade Center
85th Floor
New York, NY 10007
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com

SOURCE Halper Sadeh LLP